References
1. Janker J, Geerlings M, Schmand B. Are memory complaints predicitive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry 2000;15: 983-991.
1a. Sawabe M. Vascular aging: from molecular mechanism to clinical significance. Geriatr Gerontol Int 2010;10(Suppl 1): S213-S220.
2. Finch CE, Tanzi RE. Genetics of aging. Science 1997;278:407-411.
3. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1957;2:298-300.
4. Terman A, Brunk UT. Oxidative stress, accumulation of biological garbage, and aging. Antioxid Redox Signal 2006;1:197-204.
5. Malinin NL, West XZ, Byzova TV. Oxidation as ‘‘the stress of life.’’ Aging (Albany NY) 2011;3:906-910.
6. Hekimi S, Lapointe J, Wen Y. Taking a ‘‘good’’ look at free radicals in the aging process. Trends Cell Biol 2011;21:569-576.
7. Venkataraman K, Khurana S, Tai TC. Oxidative stress in aging Y matters of the heart and mind. Int J Mol Sci 2013;14:17897-925.
8. Malhotra JD, Miao H, Zhang K, et al. Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. PNAS 2008;105:18525-18530.
9. Martin GM. Genetics and the pathobiology of ageing. Philos Trans R Soc Lond B Biol Sci 1997;352:1773-1780.
10. Martin GM, Austad SN, Johnson TE. Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nat Genet 1996;13:25-34.
11. Humphries KM, Szweda PA, Szweda LI. Aging: a shift from redox regulation to oxidative damage. Free Radic Res 2006;40:1239-1243.
12. Islam MT. Anxioxidant activities of dithiol alpha-lipoic acid. Bangladesh J Med Sci 2009;8:1-5.
13. Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev 2008;66:646-657.
14. Huang EA, Gitelman SE. The effect of alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2008;9:69-73.
15. Evans JL, Heymann CJ, Goldfine ID, et al. Pharmacokinetics tolerability, and fructosamine-lowering effect of a novel, controlled release formulation of alpha-lipoic acid. Endocr Pract 2002;8:29-35.
16. Gulliams T. Time-Release Lipoic Acid: More Marketing than Data. Stevens Point, WI: Point Institute; 2007: pp 1-6.
17. Farr SA, Poon HF, Dogrukol-Ak D, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 2003;84:1173-1183.
18. Lovell MA, Xie C, Xiong S, et al. (2003). Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha-lipoic acid. J Alzheimers Dis 2003;5:229-239.
19. Cummings BP, Stanhope KL, Graham JL, et al. Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid. Am J Physiol Regul Integr Comp Physiol 2010;298:R1343-R1350.
20. Maczurek A, Hager K, Kenklies M, et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer’s disease. Adv Drug Deliv Rev 2008;60:1463-1470.
21. Ziegler D, Schatz H, Conrad F, et al. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 1997;20:369-373.
22. Heitzer T, Finckh B, Albers S, et al. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001;31:53-61.
23. Serbinova E, Khwaja S, Reznick AZ, et al. Thioctic acid protects against ischemia-reperfusion injury in the isolated perfused Langendorff heart. Free Radic Res Commun 1992;17:49-58.
24. Bae EH, Lee KS, Lee J, et al. Effects of alpha-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats. Am J Physiol Renal Physiol 2008;294:F272-F280.
25. Vasdev S, Gill V, Longerich L, et al. Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation. Mol Cell Biochem 2003;254:319-326.
26. Vasdev S, Gill V, Parai S, et al. Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats. Mol Cell Biochem 2005;275:135-141.
27. Hoffman MA, Tritschler HJ, Bierhaus A, et al. Lipoate effects on atherogenesis. In: Fuchs J, Packer L, Zimmer G, eds. Lipoic Acid in Health and Disease. New York: Marcel Dekker; 2000: pp 321-336.
28. Tardif J-C, Bourassa MG, eds. Developments in Cardiovascular Medicine: Antioxidants and Cardiovascular Disease. Vol 233 Amsterdam: Kluwer Academic Press; 2000.
29. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.
30. Kagan W, Kuklinski B, Ruhlmann C, et al. Recycling of vitamin E in human low density lipoproteins. J Lipid Res 1992;33:385-397 [Abstract] .
31. Angelucci L, Mascitelli-Coriandoli E. Anticholesterol activity of alpha-lipoic acid. Nature 1958;181:911-912.
32. Ivanov VN. Effect of lipoic acid on tissue respiration in rabbits with experimental atherosclerosis. Cor Vasa 1974;16:141-150.
33. Shih JC. Atherosclerosis in Japanese quail and the effect of lipoic acid. Fed Proc 1983;42:2494-2497.
34. Ford I, Cotter MA, Cameron NE, et al. The effects of treatment with α-lipoic acid or evening primrose oil on vascular haemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism 2001;50:868-875.
35. Borcea V, Nourooz-Zadeh J, Wolff SP, et al. Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med 1999;26:1495-1500.
36. Androne L, Gavan NA, Veresiu IA, et al. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy. In Vivo 2000;14:327-330.
37. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 1995;38:1425-1433.
38. Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 1997;46(Suppl 2):S62-S66.
39. Head KA. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev 2006;11:294-329.
40. Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with α-lipoic acid: the SYDNEY trial. Diabetes Care 2003;26:770-776.
41. Tankova T, Koev D, Dakovska L. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study). Rom J Intern Med 2004;42:457-464.
42. Shenk J, Liu J, Fischbach K, et al. The effect of acetyl-L-carnitine and lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer’s disease. J Neurol Sci 2009;283:199-206.
43. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013;368:1489-1497.
44. Kim KM, Jung BH, Paeng KJ, et al. Increased urinary F(2)-isoprostanes levels in the patients with Alzheimer’s disease. Brain Res Bull 2004;64:47-51.
45. Montine TJ, Markesbery WR, Morrow JD, et al. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer’s disease. Ann Neurol 1998;44:410-413.
46. Department of Veterans Affairs/Oregon Health and Science University. Prevention of Cisplatin Ototoxicity with the Antioxidant Alpha-Lipoic Acid. clinicaltrials.gov identifier NCT00477607. 2011.
47. Emory University Hospital and Grady Health System. CVD Risk and Prevention in Early Glucose Intolerance. clinicaltrials.gov identifier NCT00122447. 2012.